Key takeaway
The authors identified 423 unique wrist-worn fitness devices from 132 brands released from 2011 to 2017, and found that Fitbit, Garmin, Misfit, Apple and Polar were the five brands most used in research. Fitbit appeared in twice as many validation studies as any other brand, but only a few brands are thoroughly validated, so popularity in research is not proof of accuracy.
Study design
Research article
Reading basis
Published abstract
Reading focus
Design & applicability
The research question
New trackers and smartwatches arrive every year with different sensors and apps, and researchers need to know which can support studies and give access to the data. The authors surveyed which wrist-worn devices exist, which sensors they carry, which brands are used in research and how open they are to developers.
Who and how
Descriptive market and literature survey. Devices and brand names were searched in six wearable device databases, then supplemented from official brand websites. Only wrist-worn fitness wearables with accelerometers were included, and brand, release year and supported sensors were recorded. MEDLINE and ClinicalTrials searches determined brand use in research, and developer access to each brand's collected health data was investigated. The abstract does not report the number of studies found.
What it found
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1The search found 423 unique devices from 132 brands, and 47% of brands released only one device.
- 2New brands peaked in 2014 and the most new devices appeared in 2015. Sensor support grew every year, and the photoplethysmograph, used to estimate heart rate, was the most common sensor after the accelerometer.
- 3Among brands currently available, the five most used in research are Fitbit, Garmin, Misfit, Apple and Polar.
- 4Fitbit is used in twice as many validation studies as any other brand and is registered in ClinicalTrials studies 10 times as often as other brands.
Limits & uncertainty
- 1The survey covers devices from 2011 to 2017 only, and the market has changed, with some brands having disappeared, so it is a snapshot.
- 2Counting research use through MEDLINE and ClinicalTrials shows how often brands are chosen, not how accurate they are; the abstract reports no accuracy results.
- 3Device lists rely on six databases and brand websites, so some devices or brands may have been missed.
- 4This reading is based on the abstract only, which omits the developer data-access comparison.
What to take from it
If you choose a tracker for a personal or research project, a brand with many validation studies offers more evidence about its accuracy than one with none, though even these are not all thoroughly validated. The authors stress that the device landscape changes constantly, so check current validation evidence before relying on any model.
Reading your own data
Heart rate from optical sensors and step counts are the most widely available metrics, but values differ between brands. Stick to one device and one wear position, and compare your own trends over weeks instead of comparing numbers with someone using a different brand.
How to read this evidence
The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.
Authors’ structured abstract English
The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.
Background
New fitness trackers and smartwatches are released to the consumer market every year. These devices are equipped with different sensors, algorithms, and accompanying mobile apps. With recent advances in mobile sensor technology, privately collected physical activity data can be used as an addition to existing methods for health data collection in research. Furthermore, data collected from these devices have possible applications in patient diagnostics and treatment. With an increasing number of diverse brands, there is a need for an overview of device sensor support, as well as device applicability in research projects.
Objective
The objective of this study was to examine the availability of wrist-worn fitness wearables and analyze availability of relevant fitness sensors from 2011 to 2017. Furthermore, the study was designed to assess brand usage in research projects, compare common brands in terms of developer access to collected health data, and features to consider when deciding which brand to use in future research.
Methods
We searched for devices and brand names in six wearable device databases. For each brand, we identified additional devices on official brand websites. The search was limited to wrist-worn fitness wearables with accelerometers, for which we mapped brand, release year, and supported sensors relevant for fitness tracking. In addition, we conducted a Medical Literature Analysis and Retrieval System Online (MEDLINE) and ClinicalTrials search to determine brand usage in research projects. Finally, we investigated developer accessibility to the health data collected by identified brands.
Results
We identified 423 unique devices from 132 different brands. Forty-seven percent of brands released only one device. Introduction of new brands peaked in 2014, and the highest number of new devices was introduced in 2015. Sensor support increased every year, and in addition to the accelerometer, a photoplethysmograph, for estimating heart rate, was the most common sensor. Out of the brands currently available, the five most often used in research projects are Fitbit, Garmin, Misfit, Apple, and Polar. Fitbit is used in twice as many validation studies as any other brands and is registered in ClinicalTrials studies 10 times as often as other brands.
Conclusions
The wearable landscape is in constant change. New devices and brands are released every year, promising improved measurements and user experience. At the same time, other brands disappear from the consumer market for various reasons. Advances in device quality offer new opportunities for research. However, only a few well-established brands are frequently used in research projects, and even less are thoroughly validated.
Sources & attribution
Using Fitness Trackers and Smartwatches to Measure Physical Activity in Research: Analysis of Consumer Wrist-Worn Wearables.
Henriksen A, Haugen Mikalsen M, Woldaregay AZ, Muzny M, Hartvigsen G, Hopstock LA, Grimsgaard S.
Journal of medical Internet research · 2018-03-22
DOI: 10.2196/jmir.9157 ↗PubMed · 29567635 ↗Europe PMC · Recorded licence: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
MoveVitals editorial interpretation · educational content · no individual clinical review recorded
Sources checked 2026-11-01
Practical guides
Read in context
7,000 steps a day linked to lower risk of death, heart disease and dementia than 2,000
Compared with 2000 steps a day, 7000 steps was associated with a hazard ratio of 0.53 (95% CI 0.46 to 0.60) for all-cause mortality across 14 studies, 0.75 (0.67 to 0.85) for cardiovascular disease and 0.62 (0.53 to 0.73) for dementia; cancer incidence was not significantly different (0.94, 0.87 to 1.01). Several outcomes rest on only two to four studies, and the certainty of evidence ranged from moderate to very low.
The Lancet Public Health
Brief bursts of vigorous effort in daily life linked to lower mortality in non-exercisers
Among 25,241 UK Biobank adults who reported no leisure-time exercise, a median of 3 vigorous bouts of 1 or 2 minutes a day, picked up by a wrist accelerometer, was associated with a 38% to 40% lower risk of all-cause and cancer death and a 48% to 49% lower risk of cardiovascular death than no such bouts, over an average of 6.9 years and 852 deaths. This is an observational study using one week of wrist data and an algorithm to define vigorous effort, so it cannot show that adding such bursts causes the lower risk.
Nature Medicine
Steps and mortality: gains flatten near 6,000–8,000 (age 60+) and 8,000–10,000 (under 60)
Pooling 15 cohorts (47,471 adults, 3,013 deaths, median follow-up 7.1 years), the second, third and fourth quartiles of daily steps (medians 5,801, 7,842 and 10,901) had hazard ratios for death of 0.60, 0.55 and 0.47 against the lowest quartile (median 3,553). The curve flattened at about 6,000 to 8,000 steps a day for adults aged 60 and over and 8,000 to 10,000 for younger adults. The data are observational, from a single week of step counting, mostly with waist-worn research devices.
The Lancet Public Health
Accelerometers on 36,383 adults: any activity, even light, linked to lower mortality
In eight pooled cohorts (36,383 adults, mean age 62.6 years, 2,149 deaths over a median 5.8 years), the most active quarter by accelerometer-measured total activity had a mortality hazard ratio of 0.27 (95% CI 0.23 to 0.32) against the least active, and the most sedentary quarter had 2.63 (1.94 to 3.56). Light activity alone showed the same pattern, with 0.38 (0.28 to 0.51) in the top quarter. These are observational associations in adults aged 40 and over from the US and western Europe, so illness-driven inactivity and confounding cannot be excluded.
BMJ

